# Hemosense, Inc.

- Location (FDA's records): Milpitas, CA
- FDA decisions: 3 (2002–2007): 3 510(k) clearances
- Product codes: GJS (3)
- Predicates its devices cite: 1 (1 its own); citations of its devices by later devices: 7 (1 its own)
- Recalls linked to its devices: 10 (7 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Alere San Diego, Inc (Formally Biosite Incorporate: 3 (https://510kreport.com/company/alere-san-diego-formally-biosite-incorporate)
- Coagusense, Inc.: 2 (https://510kreport.com/company/coagusense)
- Biosite Incorporated: 1 (https://510kreport.com/company/biosite)

## Its most-cited devices
- K072727: Inratio 2 PT Monitoring System (2007), cited by 3
- K021923: Inratio Self-Test (2002), cited by 2
- K020679: Inratio (2002), cited by 2

## Recent decisions
- K072727: Inratio 2 PT Monitoring System (Oct 26, 2007)
- K021923: Inratio Self-Test (Oct 24, 2002)
- K020679: Inratio (May 6, 2002)

Source page: https://510kreport.com/company/hemosense